Kissingstents in the Aortic Bifurcation - a Valid Reconstruction for Aorto-iliac Occlusive Disease

被引:46
作者
Bjorses, K. [1 ]
Ivancev, K. [1 ]
Riva, L. [2 ]
Manjer, J. [3 ]
Uher, P. [1 ]
Resch, T. [1 ]
机构
[1] Lund Univ, Malmo Univ Hosp, Vasc Ctr, S-20502 Malmo, Sweden
[2] Dept Surg, Kristianstad, Sweden
[3] Dept Surg, Malmo, Sweden
关键词
Arterial occlusive disease; Iliac artery; Stent; Vascular patency;
D O I
10.1016/j.ejvs.2008.06.027
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To evaluate outcome and patency predicting factors of kissingstent treatment for aorto iliac occlusive disease (AICD). Methods: Patients treated with kissingstents for ACID between 1995 and 2004 at a tertiary referral center were identified through local databases. Chart review and preoperative images were used for TASC and Fontaine classification. Follow-up consisted of clinical exams, ABI and/or duplex. Patency rates were estimated by Kaplan-Meier analysis, and Cox multivariate regression was used to determine factors associated with patency. Results: 173 consecutive patients (46% mate, mean 64 years) were identified. TASC distribution was: A 15%, B 34%, C 10%, D 41%. Mean follow-up was 36 months (range: 1-144). 30-day mortality was 1% (2 patients), and 1-year survival was 91% (157 patients). 2 patients underwent [ate, open conversion and 13 patients suffered minor puncture site complications. Primary, assisted primary and secondary patency was: 97%, 99% and 100%, and 83%, 90% and 95% at twelve and 36 months respectively. There was no significant difference in patency between the TASC groups. Patency was significantly worse for patients in Fontaine class III. Conclusions: Aortoiliac kissing stents is a valid alternative to open repair for TASC A-D lesions. The procedure has tow mortality and morbidity and good patency at 3 years. (C) 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:424 / 431
页数:8
相关论文
共 28 条
  • [1] Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease
    Bosch, JL
    Hunink, MGM
    [J]. RADIOLOGY, 1997, 204 (01) : 87 - 96
  • [2] Bosiers M, 2007, J CARDIOVASC SURG, V48, P7
  • [3] Percutaneous endovascular treatment for stenoses and occlusions of infrarenal aorta and aortoiliac bifurcation:: Midterm results
    d'Othée, BJ
    Haulon, S
    Mounier-Vehier, C
    Beregi, JP
    Jabourek, O
    Willoteaux, S
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2002, 24 (06) : 516 - 523
  • [4] Results of aortic bifurcation grafts for aortoiliac occlusive disease: A meta-analysis
    deVries, SO
    Hunink, MGM
    [J]. JOURNAL OF VASCULAR SURGERY, 1997, 26 (04) : 558 - 569
  • [5] Fluoroscopy-Guided Femoral Artery Puncture Reduces the Risk of PCI-Related Vascular Complications
    Fitts, James
    Lee, Peter Ver
    Hofmaster, Patricia
    Malenka, David
    [J]. JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2008, 21 (03) : 273 - 278
  • [6] Screening algorithm for aortoiliac occlusive disease using duplex ultrasonography-acquired velocity spectra from the distal external iliac artery
    Fontcuberta, J
    Flores, A
    Langsfeld, M
    Orgaz, A
    Cuena, R
    Criado, E
    Doblas, M
    [J]. VASCULAR, 2005, 13 (03) : 164 - 172
  • [7] Percutaneous transluminal revascularization for iliac occlusive disease: Long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions
    Galaria, II
    Davies, MG
    [J]. ANNALS OF VASCULAR SURGERY, 2005, 19 (03) : 352 - 360
  • [8] Does stent overlap influence the patency rate of aortoiliac kissing stents?
    Greiner, A
    Mühlthaler, H
    Neuhauser, B
    Waldenberger, P
    Dessl, A
    Schocke, MFH
    Jaschke, W
    Fraedrich, G
    [J]. JOURNAL OF ENDOVASCULAR THERAPY, 2005, 12 (06) : 696 - 703
  • [9] Kissing stents for treatment of complex aortoiliac disease
    Greiner, A
    Dessl, A
    Klein-Weigel, P
    Neuhauser, B
    Perkmann, R
    Waldenberger, P
    Jaschke, W
    Fraedrich, G
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2003, 26 (02) : 161 - 165
  • [10] Haulon S, 2002, J ENDOVASC THER, V9, P363, DOI 10.1583/1545-1550(2002)009<0363:PROTAB>2.0.CO